Goldman Sachs and Morgan Stanley reported strong trading revenues amid market volatility, while Johnson & Johnson raised its full-year guidance despite tariff concerns. MoneyGram’s CEO discusses stablecoins as the Stablecoin Bill nears passage.
- Goldman Sachs and Morgan Stanley reported strong trading revenues despite market volatility.
- Johnson & Johnson raised its full-year guidance, signaling confidence in biopharma manufacturing returning to the US.
- MoneyGram's CEO discussed the impact of stablecoins as the Stablecoin Bill moves closer to becoming law.
📎 Related coverage from: bloomberg.com
